My M&A experience covers private treaty deals and public transactions such as schemes and takeovers. I also advise on compliance, reporting and disclosure under the Corporations Act 2001 (Cth) and Australian Securities Exchange (ASX) Listing Rules.

My clients include listed and private companies, managed investment schemes, private equity sponsors, institutional investors, and lead managers and underwriters.

Clients value my cross-border experience, having worked for a top-tier law firm in New York, as well as my practical advice and innovative solutions.

Career highlights

• Yancoal Australia Limited - advised on the A$3.2 billion equity raising to fund the acquisition of 100% of the shares in Coal & Allied
• Intermediate Capital Group – advised on the $2.5 billion IPO and ASX listing of Link Administration Holdings Limited
• Vitaco Holdings Limited – advised on the $330 million buyout and take-private of Vitaco Holdings Limited by way of a scheme of arrangement, following on from the $320 million IPO and ASX listing of Vitaco the preceding year
• Insurance Australia Group Limited – advised on $1.5 billion placement and SPP to fund its $1.85 billion acquisition of the Australian and New Zealand insurance underwriting businesses of Wesfarmers Limited
• Tegel Group Holdings Limited – advised on Tegel's $551 million initial public offering (IPO) and dual listing on the ASX and New Zealand Exchange (NZX) 
• Lloyds Banking Group – advised on the $1.55 billion sale of Lloyds' Australian asset finance business (Capital Finance Australia Limited) and corporate loan business (BOS International (Australia) Limited) to Westpac Banking Corporation
• Bellamy's Australia Limited – advised Bellamy's on the $60.4 million pro rata accelerated non renounceable entitlement offer of Bellamy’s Australia Limited 
• Joint lead managers and underwriters – advised on the $67.5 million pro rata accelerated non renounceable entitlement offer of Xenith IP Group Limited 
• Advised on ALS's $325 million pro rata accelerated non renounceable entitlement offer
• SkyCity Entertainment Group Limited – advised SkyCity on its NZ$263 million pro rata accelerated entitlement offer
• isentia Group Limited – advised on the $465 million IPO and ASX listing

• Australian Life Sciences and Biotech - Key Themes and Trends

  By Daniel Scotti |October 2018

• Australian Life Sciences and Biotech - Key Themes and Trends

  By Daniel Scotti |October 2018

• Australian Life Sciences and Biotech - Key Themes and Trends

  By Daniel Scotti, Nicole Sloggett |July 2018

• MinterEllison acts on Electro Optic Systems capital raising
  

  MinterEllison advised EOS on its capital raising as the effects of COVID-19 set in

• COVID-19: ASX amends temporary extra placement capacity waiver
  

  ASX has updated the class waiver (released on 31 March) that implements temporary emergency capital raising measures to help listed entities affected by the COVID-19 pandemic. The waiver adds disclosure requirements that clarify certain matters which primarily relate to the allocation policy and process used by issuers for placements relying on the waiver.

   

• Top 10 practical tips when preparing for an IPO
  

  Is your company an IPO candidate? If so, how can you best prepare for a successful IPO? We share some top tips to maximise your chances of success.

• Australian Life Sciences and Biotech - Key themes and trends
  The Australian life sciences and biotech sector is likely to continue its resurgence over the next twelve months, with global trends driving strong M&A activity in life sciences and biotech M&A. We have identified 6 key themes for activity in this sector.
• Catching PIPEs in the wave of COVID-19 capital raisings
  

  With dwindling cashflows, many ASX companies have started to raise capital to shore up their balance sheets. To assist those considering PIPE, here's our everything you need to know guide.

• MinterEllison advises ASX-listed MCP Master Income Trust on $381 million capital raising
  

  MinterEllison has advised ASX-listed investment trust, MCP Master Income Trust (ASX:MXT), on its proposed $381 million capital raising.

• A capital idea - ASX and ASIC relax rules for COVID-19 raisings
  

  Entities needing to urgently raise funds will now have some relief, following new steps announced by ASX and ASIC to facilitate capital raisings by listed entities impacted by COVID-19. In addition, ASX has provided guidance in relation to continuous disclosure and financial reporting obligations during the pandemic.

• Weathering uncertainty: the state of Australian equity capital markets
  

  Headwinds are blowing in capital markets globally. IPO and other equity capital markets (ECM) deal volumes are down more than 70%. As capital becomes harder to access, we explore the issues that are challenging markets and businesses. What can issuers do to put themselves in the best position to raise money or see themselves through until conditions improve?

• Yancoal Australia's US$2.5bn equity raising - A landmark deal
  

  MinerEllison co-advised Yancoal Australia Limited's US$2.5 billion equity raising, which provided funding for the acquisition of 100% of the shares in Coal & Allied from wholly-owned subsidiaries of Rio Tinto Limited.